Quelle

Literatura:
Chambers C.S., Valentnova K., Kren V., „Non-Taxifolin” Derived Flavonolignans: Phytochemistry and Biology, Curr Pharm Des. 2015,
Manigandan K., Manimaran D. i in., Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis, Biochimie. 2015,
Nam Y.J., Lee D.H. i in., Flavanonol taxifolin attenuates proteasome inhibition-induced apoptosis in differentiated PC12 cells by suppressing cell death process, Neurochem Res. 2015,
Park Sy, Kim H.Y. i in., Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways, PLoS One. 2016,
Satue M., Arriero Mdel M. i in., Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells, Biochem Pharmacol. 2013,
Sun X., Chen R.C. i in., Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis, Food Chem Toxicol. 2014,
Topal F., Nar M. i in., Antioxidant activity of taxifolin: an activity-structure relationship, J Enzyme Inhib Med Chem. 2016.